SomaLogic, Inc.
NASDAQ:SLGC
2.1 (USD) • At close January 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 22.048 | 20.468 | 20.379 | 18.829 | 41.713 | 14.144 | 22.98 | 22.994 | 19.992 | 19.78 | 18.86 | 28.223 | 14.233 |
| Cost of Revenue
| 11.635 | 11.175 | 12.316 | 12.965 | 11.67 | 7.077 | 11.652 | 10.463 | 8.77 | 7.985 | 6.245 | 10.234 | 4.913 |
| Gross Profit
| 10.413 | 9.293 | 8.063 | 5.864 | 30.043 | 7.067 | 11.328 | 12.531 | 11.222 | 11.795 | 12.615 | 17.989 | 9.32 |
| Gross Profit Ratio
| 0.472 | 0.454 | 0.396 | 0.311 | 0.72 | 0.5 | 0.493 | 0.545 | 0.561 | 0.596 | 0.669 | 0.637 | 0.655 |
| Reseach & Development Expenses
| 10.458 | 10.815 | 14.067 | 22.589 | 19.419 | 17.636 | 13.8 | 11.192 | 15.596 | 8.59 | 8.118 | 7.569 | 6.884 |
| General & Administrative Expenses
| 0 | 0 | 0 | 34.256 | 0 | 0 | 0 | 0.798 | 0 | 0.798 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 3.5 | 0 | 0 | 0 | -14.035 | 0 | 14.035 | 0 | 0 | 0 |
| SG&A
| 23.88 | 29.573 | 34.189 | 37.756 | 51.236 | 36.812 | 30.815 | 29.697 | 20.632 | 14.833 | 12.809 | 10.127 | 8.337 |
| Other Expenses
| 5.798 | 1.498 | 0.634 | 43.364 | 0.406 | 0.506 | 0.272 | 33.463 | 0.033 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 34.338 | 40.388 | 48.256 | 60.345 | 70.655 | 54.448 | 44.615 | 40.889 | 36.228 | 23.423 | 20.927 | 17.696 | 15.221 |
| Operating Income
| -28.082 | -31.095 | -40.193 | -54.481 | -40.612 | -47.381 | -33.287 | -28.358 | -25.006 | -11.628 | -8.312 | 0.293 | -5.901 |
| Operating Income Ratio
| -1.274 | -1.519 | -1.972 | -2.893 | -0.974 | -3.35 | -1.449 | -1.233 | -1.251 | -0.588 | -0.441 | 0.01 | -0.415 |
| Total Other Income Expenses Net
| -3.841 | 0.527 | 5.993 | 5.135 | 7.048 | 24.396 | 29.308 | 4.952 | -16.466 | -1.63 | -1.172 | -9.207 | -1.582 |
| Income Before Tax
| -21.679 | -24.77 | -34.2 | -49.346 | -33.564 | -22.985 | -3.979 | -23.307 | -41.419 | -13.337 | -9.484 | -8.914 | -7.483 |
| Income Before Tax Ratio
| -0.983 | -1.21 | -1.678 | -2.621 | -0.805 | -1.625 | -0.173 | -1.014 | -2.072 | -0.674 | -0.503 | -0.316 | -0.526 |
| Income Tax Expense
| 0.478 | 0.002 | 0.002 | -0.095 | -0.622 | -24.396 | -29.308 | 0.273 | 16.413 | 1.709 | 1.172 | 9.207 | -0.013 |
| Net Income
| -22.157 | -24.772 | -34.202 | -49.251 | -32.942 | 1.411 | 25.329 | -23.307 | -41.419 | -13.337 | -9.484 | -8.914 | -7.483 |
| Net Income Ratio
| -1.005 | -1.21 | -1.678 | -2.616 | -0.79 | 0.1 | 1.102 | -1.014 | -2.072 | -0.674 | -0.503 | -0.316 | -0.526 |
| EPS
| -0.12 | -0.13 | -0.18 | -0.26 | -0.18 | 0.008 | 0.14 | -0.13 | -0.3 | -0.12 | -0.052 | -0.049 | -0.041 |
| EPS Diluted
| -0.12 | -0.13 | -0.18 | -0.26 | -0.18 | 0.008 | 0.14 | -0.13 | -0.3 | -0.12 | -0.052 | -0.049 | -0.041 |
| EBITDA
| -18.184 | -29.732 | -41.261 | -49.888 | -37.023 | -45.585 | -33.081 | -28.259 | -24.419 | -10.885 | -7.607 | 1.129 | -5.888 |
| EBITDA Ratio
| -0.825 | -1.453 | -2.025 | -2.65 | -0.888 | -3.223 | -1.44 | -1.229 | -1.221 | -0.55 | -0.403 | 0.04 | -0.414 |